Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Erectile dysfunction in diabetic patients.

Joumana T Chaiban1, Sami T Azar

  • 1Endocrinology Division, Department of Internal Medicine, American University of Beirut-Medical Center, Beirut, Lebanon.

Le Journal Medical Libanais. the Lebanese Medical Journal
|January 26, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Urinary 20-HETE: A prospective Non-Invasive prognostic and diagnostic marker for diabetic kidney disease.

Journal of advanced research·2023
Same author

Recommendations for Early and Comprehensive Management of Type 2 Diabetes and Its Related Cardio-Renal Complications.

Diabetes therapy : research, treatment and education of diabetes and related disorders·2022
Same author

COVID-19 Vaccine-Associated Lymphadenopathy in Breast Imaging Recipients: A Review of Literature.

Cureus·2022
Same author

Diabetic ketoacidosis.

Disease-a-month : DM·2022
Same author

Reno-Protective Effect of GLP-1 Receptor Agonists in Type1 Diabetes: Dual Action on TRPC6 and NADPH Oxidases.

Biomedicines·2021
Same author

Diabetic Nephropathy and COVID-19: The Potential Role of Immune Actors.

International journal of molecular sciences·2021
Same journal

SMOKING · WE DO NOT WANT TO QUIT!.

Le Journal medical libanais. The Lebanese medical journal·2018
Same journal

CIRCULATING microRNAs: POTENTIAL BIOMARKERS IN CANCER DETECTION, DIAGNOSIS AND PROGNOSIS.

Le Journal medical libanais. The Lebanese medical journal·2018
Same journal

AUTISM IN REVIEW.

Le Journal medical libanais. The Lebanese medical journal·2018
Same journal

[Not Available].

Le Journal medical libanais. The Lebanese medical journal·2018
Same journal

RELATIONSHIP OF PERSONALITY TRAITS WITH ANXIETY, DEPRESSIVE AND PTSD SYMPTOMATOLOGY AND ACADEMIC PERFORMANCE. Experience with an Arab college student sample.

Le Journal medical libanais. The Lebanese medical journal·2018
Same journal

EARLY INCREASE of CA 19-9 in ADVANCED PANCREATIC CANCER RECEIVING FOLFIRINOX. Is it a sign of efficacy?.

Le Journal medical libanais. The Lebanese medical journal·2018
See all related articles

Erectile dysfunction (ED) is common and severe in diabetic patients, often linked to vascular issues and poor diabetes control. A comprehensive treatment approach is essential for optimal outcomes.

Area of Science:

  • Endocrinology
  • Cardiology
  • Urology

Background:

  • Erectile dysfunction (ED) affects approximately 50% of men around age 50 with diabetes.
  • Diabetic ED is often more severe and multifactorial compared to the general population.
  • ED in diabetics is linked to vascular risk factors, endothelial dysfunction, and silent coronary atherosclerosis.

Purpose of the Study:

  • To highlight the high prevalence and severity of ED in diabetic patients.
  • To underscore the multifactorial etiology of ED in this population.
  • To advocate for a comprehensive management strategy for diabetic ED.

Main Methods:

  • Review of existing literature on erectile dysfunction in diabetic patients.
  • Analysis of the correlation between ED, vascular risk factors, and diabetes control.

Related Experiment Videos

  • Identification of key components for a multifactorial treatment approach.

    • Main Results:

    • ED is highly prevalent (approx. 50% at age 50) and severe in diabetic individuals.
    • Etiology is multifactorial, involving vascular risk factors, endothelial dysfunction, and diabetes complications.
    • ED can serve as an early indicator of underlying coronary atherosclerosis.

    Conclusions:

    • A multifactorial approach is crucial for effectively treating ED in diabetic patients.
    • Key treatment components include optimizing diabetes control, using phosphodiesterase 5 inhibitors, psychosexual counseling, and careful selection of antihypertensive medications.
    • Addressing ED in diabetics requires a holistic strategy considering metabolic, vascular, and psychological aspects.